Financhill
Back

CASI Pharmaceuticals Quote, Financials, Valuation and Earnings

Sell
46

CASI
CASI Pharmaceuticals

Last Price:
3.24
Seasonality Move:
-12.73%

7 Day Trial

ALL ACCESS PASS

$ 7

CASI Pharmaceuticals Price Quote

$3.24
0.00 (-0.92%)
(Updated: May 17, 2024 at 5:03 AM ET)

CASI Pharmaceuticals Key Stats

Sell
46
CASI Pharmaceuticals (CASI) is a Sell

Day range:
$3.00 - $3.54
52-week range:
$1.85 - $8.48
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.28
P/B ratio:
1.8%

Volume:
17K
Avg. volume:
25.5K
1-year change:
29.97%
Market cap:
$43.5M
Revenue:
$33.9M
EPS:
$-2.03

How Much Does CASI Pharmaceuticals Make?

Is CASI Pharmaceuticals Growing As A Company?

  • What Is CASI Pharmaceuticals's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.55%
  • What Is CASI Pharmaceuticals's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

CASI Pharmaceuticals Stock Price Performance

What Is CASI Pharmaceuticals 52-Week High & Low?

CASI Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy CASI Pharmaceuticals?

Is CASI Pharmaceuticals Cash Flow Positive?

Data Unavailable

CASI Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    CASI return on invested capital is -48.71%
  • What Is CASI Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -32.69%
  • What Is CASI Return On Equity?
    ROE is a measure of profitability and is -52.29%

CASI Pharmaceuticals Earnings Date & Stock Price

CASI Pharmaceuticals Competitors

  • Who Are CASI Pharmaceuticals's Competitors?
    Below is a list of companies who compete with CASI Pharmaceuticals or are related in some way:
    • BIMI International Medical Inc (BIMI)
    • China Health Industries Holdings Inc (CHHE)
    • China Pharma Holding Inc (CPHI)
    • Linike Medical Group Ltd (LNMG)
    • Meihua International Medical Technologies Co Ltd (MHUA)

CASI Pharmaceuticals Dividend Yield

Data Unavailable

CASI Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: -54.95% -71.59%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 12.00
Upside from Last Price: 269.8%

Major Shareholders

  • How many CASI shares are owned by institutional investors?
    335.9K CASI shares are owned by institutional investors
  • How many CASI shares are owned by insiders?
    1.9M CASI shares are owned by insiders